Unveiling the Elevated Risk of Osteoporosis and Fractures in Idiopathic Inflammatory Myopathies: Emphasizing Awareness of Modifiable Risk Factors

Ilke Coskun Benlidayi¹, Helene Alexanderson^{2

3}, Latika Gupta^{4

5}

Affiliations

¹ Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye.
² Theme Women's Health and Allied Health Professionals, Medical Unit Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
⁴ Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
⁵ Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

Editorial

Ilke Coskun Benlidayi et al. Int J Rheum Dis. 2024 Dec.

. 2024 Dec;27(12):e15451.

doi: 10.1111/1756-185X.15451.

Ilke Coskun Benlidayi¹, Helene Alexanderson^{2

3}, Latika Gupta^{4

5}

¹ Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Cukurova University, Adana, Türkiye.
² Theme Women's Health and Allied Health Professionals, Medical Unit Allied Health Professionals, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet, Stockholm, Sweden.
⁴ Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
⁵ Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

No abstract available

Keywords: bone and bones; bone mineral density; fractures; idiopathic inflammatory myopathies; osteoporosis.

References

1. B. I. Coskun, “Bone Health in Autoimmune Inflammatory Rheumatic Diseases,” in Translational Immunology, Translational Autoimmunity, vol. 6, ed. N. Rezaei (Elsevier‐Academic Press, 2023), 9–26, https://doi.org/10.1016/B978‐0‐323‐85831‐1.00002‐4.
1. I. Y. K. Tang, L. Luk, V. Wong, S. Pang, V. Lao, and H. So, “Reduced Bone Mineral Density in Patients With Idiopathic Inflammatory Myopathies: A Case‐Control Study,” Therapeutic Advances in Musculoskeletal Disease 16, no. 15 (2023): 1759720X231181968, https://doi.org/10.1177/1759720X231181968.
1. D. C. de Andrade, S. C. de Magalhães Souza, J. F. de Carvalho, et al., “High Frequency of Osteoporosis and Fractures in Women With Dermatomyositis/Polymyositis,” Rheumatology International 32, no. 6 (2012): 1549–1553, https://doi.org/10.1007/s00296‐011‐1821‐2.
1. C. W. Lee, C. H. Muo, J. A. Liang, F. C. Sung, C. Y. Hsu, and C. H. Kao, “Increased Osteoporosis Risk in Dermatomyositis or Polymyositis Independent of the Treatments: A Population‐Based Cohort Study With Propensity Score,” Endocrine 52, no. 1 (2016): 86–92, https://doi.org/10.1007/s12020‐015‐0756‐x.
1. A. Valle, S. Narain, M. L. Barilla‐Labarca, and G. Marder, “The Differential Role of SSa/SSb and Ro52 Antibodies in Defining Clinical Phenotypes in Idiopathic Inflammatory Myopathies,” Seminars in Arthritis and Rheumatism 65 (2024): 152407, https://doi.org/10.1016/j.semarthrit.2024.152407.